Evidence map›Paper›PMID 41943822›Full record

ArticleJBMR plus2026

A rare coexistence: Ollier disease and primary hyperparathyroidism-mere coincidence or expanding the spectrum of Ollier disease?

Justine Luciano, Astrid Dauchez, Beatrix Cochand-Priollet, Antonin Ginguay, Charlotte Melot, Caroline Michot, Mevyn Nizard, Sophie Monnot, Frédéric Sailhan, Valérie Cormier-Daire and 1 more

Abstract readCase Reports
In one paragraph

Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Justine LucianoRheumatology Department, Reference Centre for Rare Bone Disorders, Cochin-Constitutive Site, Cochin Hospital, AP-HP Centre-Paris University, 75014 Paris, France.ORCID https://orcid.org/0009-0002-5131-714X
Astrid DauchezRheumatology Department, Reference Centre for Rare Bone Disorders, Cochin-Constitutive Site, Cochin Hospital, AP-HP Centre-Paris University, 75014 Paris, France.
Beatrix Cochand-PriolletDepartment of Pathology, Cochin Hospital, AP-HP Centre-Paris University, 75014 Paris, France.
Antonin GinguayDepartment of Automated Biological Diagnostic, Cochin Hospital, AP-HP Centre-Université de Paris, 75679 Paris, France.
Charlotte MelotDepartment of Hepato-Pancreatic-Biliary and Endocrine Surgery, Cochin Hospital, AP-HP Centre-Paris Cité University, 75013 Paris, France.
Caroline MichotDepartment of Genomic Medicine for Rare Diseases, Necker-Enfants Malades Hospital, French Reference Centre for Constitutional Bone Diseases, INSERM UMR 1163, Imagine Institute, Paris Cité University, 75014 Paris, France.
Mevyn NizardDepartment of Genomic Medicine for Rare Diseases, Necker-Enfants Malades Hospital, French Reference Centre for Constitutional Bone Diseases, INSERM UMR 1163, Imagine Institute, Paris Cité University, 75014 Paris, France.
Sophie MonnotDepartment of Genomic Medicine for Rare Diseases, Necker-Enfants Malades Hospital, French Reference Centre for Constitutional Bone Diseases, INSERM UMR 1163, Imagine Institute, Paris Cité University, 75014 Paris, France.
Frédéric SailhanDepartment of Orthopaedic Surgery, Cochin Hospital, AP-HP Centre-Paris Cité University, 75014 Paris, France.
Valérie Cormier-DaireDepartment of Genomic Medicine for Rare Diseases, Necker-Enfants Malades Hospital, French Reference Centre for Constitutional Bone Diseases, INSERM UMR 1163, Imagine Institute, Paris Cité University, 75014 Paris, France.
Eugénie KoumakisRheumatology Department, Reference Centre for Rare Bone Disorders, Cochin-Constitutive Site, Cochin Hospital, AP-HP Centre-Paris University, 75014 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ollier disease (OD) is the most common form of multiple enchondromatosis. It is an extremely rare disorder characterized by the development of multiple benign cartilaginous tumors, known as enchondromas. The prognosis is mainly determined by the risk of malignant transformation, which occurs in approximately 50% of patients within the first 30 yr of life. The disease is caused by somatic gain-of-function mutations in the

Indexed as

IDH1IDH2Maffucci syndromemultiple enchondromatosisOllier diseaseprimary hyperparathyroidism

Identifiers

PMID41943822
PMCPMC13050500

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.